Saba Capital sells 26,644 BlackRock ECAT shares
A more than 10% holder of ECAT reported an open-market sale of 26,644 indirectly held shares, leaving over 12.7 million shares reported as still held.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BlackRock ESG Capital Allocation Term Trust (ECAT) had a Form 4 filed reporting that Saba Capital Management, L.P., a more than 10% holder, sold 26,644 shares of Common Stock on September 14, 2026, at $14.59 per share in an open-market or private transaction. Following this sale, Saba Capital Management, L.P. reported 12,738,931 shares held indirectly. No Rule 10b5-1 trading plan is reported for this transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 26,644 | $14.59 | $389K |
Key Figures
Key Terms
indirect ownership financial
more than 10% owner regulatory
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction in ECAT did Saba Capital Management, L.P. report?
Was the ECAT insider sale by Saba Capital made under a Rule 10b5-1 plan?
Is Saba Capital Management, L.P. a major holder of ECAT?
AI-generated analysis. How Rhea-AI works. Not financial advice.